Psilocybin Could Help Treat Nearly 264 Million with Depression

Mental health is on the decline all over the world.  In fact, as you read this, nearly 264 million people are struggling with depression, for example.  While some of us are better at hiding our depression than others, it can be a real struggle, especially with the potential anxiety, irritability, and hopelessness.  Many even “put … Continue reading Psilocybin Could Help Treat Nearly 264 Million with Depression

With Psychedelics, Mental Health Care May Never be the Same

With psychedelics, mental health care may never be the same.  All as some of the nation’s “top universities are racing to set up psychedelic research centers, and investors are pouring millions of dollars into a pack of start-ups. States and cities across the country are beginning to loosen restrictions on the drugs, the first steps … Continue reading With Psychedelics, Mental Health Care May Never be the Same

Gummies Another Popular Way to Consume CBD

CBD gummies could offer investors a multi-billion-dollar opportunity.  In fact, according to Hemp Industry Daily, “Considering that the market could see favorable U.S. Food and Drug Administration guidance or legislation from Congress approving CBD in ingestible products next year, Nielsen expects that by 2025, the market for hemp-derived CBD products will generate $6.9 billion, – … Continue reading Gummies Another Popular Way to Consume CBD

Moderna (MRNA) Advances to Next Stage of Vaccine Testing

We may be nearing a coronavirus vaccine. Just yesterday, Moderna (MRNA) announced it submitted an Investigational New Drug (IND) application to the US FDA for its mRNA candidate to “evaluate mRNA-1273 in Phase 2 and late-stage studies if supported by safety data from the Phase 1 study led by the National Institute of Allergy and … Continue reading Moderna (MRNA) Advances to Next Stage of Vaccine Testing